Normal view

Received — 10 September 2026 ⏭ Molecular Therapy

Molecular Therapy
MITF-SCD1 Lipid Metabolic Axis Prevents Ouabain-Induced Spiral Ganglion Neuron Ferroptosis and Hearing Loss Xue Wang · Fang Chen · Ziji Zhang · Man Zhang · Man Wang · Lei Chen · Anqi Suo · Xugang Zhuang · Tenghan Ling · Renjie Chai · Haibo Wang · Bo Chu · Lei Xu · Wenwen Liu
Ouabain triggers cochlear spiral ganglion neuron (SGN) ferroptosis and hearing loss via SCD1 downregulation. MITF directly activates Scd1 transcription, and the MITF–SCD1 axis mitigates SGN ferroptosis and hearing impairment in ototoxic ouabain and cisplatin models, revealing a lipid metabolic vulnerability and therapeutic target for sensorineural hearing loss.
31 August 2026 at 08:00

MITF-SCD1 Lipid Metabolic Axis Prevents Ouabain-Induced Spiral Ganglion Neuron Ferroptosis and Hearing Loss

By: Xue Wang · Fang Chen · Ziji Zhang · Man Zhang · Man Wang · Lei Chen · Anqi Suo · Xugang Zhuang · Tenghan Ling · Renjie Chai · Haibo Wang · Bo Chu · Lei Xu · Wenwen Liu

31 August 2026 at 08:00

Ouabain triggers cochlear spiral ganglion neuron (SGN) ferroptosis and hearing loss via SCD1 downregulation. MITF directly activates Scd1 transcription, and the MITF–SCD1 axis mitigates SGN ferroptosis and hearing impairment in ototoxic ouabain and cisplatin models, revealing a lipid metabolic vulnerability and therapeutic target for sensorineural hearing loss.